An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

C.M. Sanders, C.A. Langley, J. Persaud, J.F. Marriott, K.A. Wilson

Research output: Contribution to journalConference abstractpeer-review

Abstract

Poster session
- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form
- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent
- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity
- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol
- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination
Original languageEnglish
Pages (from-to)R37
Number of pages1
JournalInternational Journal of Pharmacy Practice
Volume11
Issue numberS1
DOIs
Publication statusPublished - Sep 2003
EventBritish Pharmaceutical Conference 2003 - Harrogate, United Kingdom
Duration: 15 Sep 200317 Sep 2003

Fingerprint

Dive into the research topics of 'An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients'. Together they form a unique fingerprint.

Cite this